Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Browse creative work from home business ideas that can help you start earning. Discover the perfect fit for your skills!
18,910 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Curious about building decades of passive income through resilient dividends? This guide breaks down three energy sto...
Palo Alto Networks’ stock rose after the cybersecurity firm posted solid quarterly results and highlighted AI-driven ...
A public rebuke of management sparks a wave of worker stories about the price of speaking up at work and how it affec...
IBM is shifting to a software-led model with accelerating cash flow and a higher dividend, signaling a durable, AI-ti...
Marvell Technology is about to join the S&P 500 on June 22, 2026, after a 57% rally in the last 30 days. Market watch...
As the spot Bitcoin ETF field consolidates, IBIT and FBTC remain the leading contenders. Both own actual Bitcoin and ...
June brings a wave of AI-focused optimism to fintech stocks. Nu Holdings shines as AI-powered lending gains attention...
Alphabet is branching far beyond search, funding a sweeping AI infrastructure push. This article unpacks why wall str...
A private equity buyer has acquired the publishing stake in two Taylor Swift co-written hits, signaling a new frontie...
A downtown Pittsburgh convenience store is at the center of allegations that SNAP benefits were converted to cash and...
Analysts warn that the CLARITY Act's odds of passing have fallen below 50% as the Senate's August recess approaches. ...